Reverse engineering for new oral anticoagulants: Non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban

被引：6

作者：

Levi, Marcel ^{[1
]}

机构：

[1] Univ Amsterdam, Dept Med, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

来源：

THROMBOSIS AND HAEMOSTASIS | 2012年 / 108卷 / 02期

关键词：

PROTHROMBIN COMPLEX CONCENTRATE; RECOMBINANT FACTOR VIIA; INHIBITOR; THROMBIN; PREVENTION; THERAPY; RISK;

D O I：

10.1160/TH12-05-0330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：201 / 202

页数：2

共 17 条

[1] New oral anticoagulant drugs in cardiovascular disease [J].

Ahrens, Ingo ;

Lip, Gregory Y. H. ;

Peter, Karlheinz .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60

[2] Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers [J].

Bijsterveld, NR ;

Moons, AH ;

Boekholdt, SM ;

van Aken, BE ;

Fennema, H ;

Peters, RJG ;

Meijers, JCM ;

Büller, HR ;

Levi, M .

CIRCULATION, 2002, 106 (20) :2550-2554

[3] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].

Eerenberg, Elise S. ;

Kamphuisen, Pieter W. ;

Sijpkens, Meertien K. ;

Meijers, Joost C. ;

Buller, Harry R. ;

Levi, Marcel .

CIRCULATION, 2011, 124 (14) :1573-1579

[4] Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents [J].

Fukuda, Toshio ;

Honda, Yuko ;

Kamisato, Chikako ;

Morishima, Yoshiyuki ;

Shibano, Toshiro .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) :253-259

[5] Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model [J].

Godier, Anne ;

Miclot, Anastasia ;

Le Bonniec, Bernard ;

Durand, Marion ;

Fischer, Anne-Marie ;

Emmerich, Joseph ;

Marchand-Leroux, Catherine ;

Lecompte, Thomas ;

Samama, Charles-Marc .

ANESTHESIOLOGY, 2012, 116 (01) :94-102

[6] Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents [J].

Levi, M. ;

Eerenberg, E. ;

Kamphuisen, P. W. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (09) :1705-1712

[7]

Levi M, 2011, NETH J MED, V69, P268

[8]

Levi MM, 2010, NETH J MED, V68, P68

[9] Drug therapy: Prevention and treatment of major blood loss [J].

Mannucci, Pier Mannuccio ;

Levi, Marcel .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2301-2311

[10] Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban [J].

Marlu, Raphael ;

Hodaj, Enkelejda ;

Paris, Adeline ;

Albaladejo, Pierre ;

Crackowski, Jean Luc ;

Pernod, Gilles .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) :217-224

← 1 2 →